ATE458495T1 - Therapeutische zubereitung für autoimmune erkrankungen - Google Patents

Therapeutische zubereitung für autoimmune erkrankungen

Info

Publication number
ATE458495T1
ATE458495T1 AT04726221T AT04726221T ATE458495T1 AT E458495 T1 ATE458495 T1 AT E458495T1 AT 04726221 T AT04726221 T AT 04726221T AT 04726221 T AT04726221 T AT 04726221T AT E458495 T1 ATE458495 T1 AT E458495T1
Authority
AT
Austria
Prior art keywords
autoimmune diseases
therapeutic preparation
composition
given
therapeutic
Prior art date
Application number
AT04726221T
Other languages
English (en)
Inventor
Simon Mcewen
Original Assignee
Epidyme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epidyme Ltd filed Critical Epidyme Ltd
Application granted granted Critical
Publication of ATE458495T1 publication Critical patent/ATE458495T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04726221T 2003-04-07 2004-04-07 Therapeutische zubereitung für autoimmune erkrankungen ATE458495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307989.4A GB0307989D0 (en) 2003-04-07 2003-04-07 Therapeutic composition
PCT/GB2004/001562 WO2004089405A1 (en) 2003-04-07 2004-04-07 Therapeutic composition for autoimmune conditions

Publications (1)

Publication Number Publication Date
ATE458495T1 true ATE458495T1 (de) 2010-03-15

Family

ID=9956332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04726221T ATE458495T1 (de) 2003-04-07 2004-04-07 Therapeutische zubereitung für autoimmune erkrankungen

Country Status (11)

Country Link
US (2) US7901676B2 (de)
EP (1) EP1610814B8 (de)
JP (1) JP2006522086A (de)
CN (1) CN1802172A (de)
AT (1) ATE458495T1 (de)
CA (1) CA2521602A1 (de)
DE (1) DE602004025683D1 (de)
GB (2) GB0307989D0 (de)
HK (1) HK1087328A1 (de)
MX (1) MXPA05010790A (de)
WO (1) WO2004089405A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
CA2714401C (en) * 2007-12-12 2021-01-12 Dacy Tech Pty Ltd Composition comprising extracts of biota orientalis and use thereof for treating cartilage inflammation
US10376550B2 (en) 2007-12-12 2019-08-13 Dacy Tech Pty Ltd. Nutraceutical composition and methods of use
WO2009073930A1 (en) * 2007-12-12 2009-06-18 Dacy Tech Pty Ltd Nutraceutical composition and methods of use
ITMI20080357A1 (it) * 2008-03-04 2009-09-05 Sarm Allergeni Srl Proteina da haliotis midae e suo uso come agente immunoterapico
SG10201601905RA (en) * 2016-03-11 2017-10-30 Kah Meng Lim Extract And Method of Extraction

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2620649C3 (de) 1976-05-11 1980-11-06 Behringwerke Ag, 3550 Marburg Immunologisches Adjuvans
US5268463A (en) * 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
GB8713906D0 (en) 1987-06-15 1987-07-22 Mcewen L M Beta-glucuronidase containing compositions
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
DE4125400C2 (de) * 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
DE19828450A1 (de) * 1998-06-26 1999-12-30 Hassan Jomaa Bisphosphonsäuren und deren Derivate enthaltende Arzneimittel zur Prophylaxe und zur Behandlung von Autoimmunkrankheiten sowie von Allergien
CA2344269A1 (en) * 1998-10-07 2000-04-13 Syngenta Participations Ag Therapeutically active proteins in plants
US6162787A (en) 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
WO2001070663A2 (en) * 2000-03-17 2001-09-27 Corixa Corporation Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
EP1228767A1 (de) 2001-01-31 2002-08-07 S.A.R.M. S.r.l. Verwendung der beta-Glukuronidase zur Behandlung von Immun- oder allergischen Krankheiten
CN1516595A (zh) * 2001-03-19 2004-07-28 Iomai公司 用于经皮免疫的贴剂
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
ATE414534T1 (de) * 2001-12-05 2008-12-15 Circassia Ltd Immunotherapeutische methoden und systeme
GB0307989D0 (en) * 2003-04-07 2003-05-14 Mcewen Lab Ltd Therapeutic composition
US9549959B2 (en) * 2006-09-15 2017-01-24 I Did It, Inc. Animal chew toy containing solid food

Also Published As

Publication number Publication date
GB2400556A (en) 2004-10-20
CA2521602A1 (en) 2004-10-21
US20110135624A1 (en) 2011-06-09
JP2006522086A (ja) 2006-09-28
GB2400556B (en) 2005-10-19
EP1610814B1 (de) 2010-02-24
DE602004025683D1 (de) 2010-04-08
WO2004089405A1 (en) 2004-10-21
US7901676B2 (en) 2011-03-08
CN1802172A (zh) 2006-07-12
US20040228850A1 (en) 2004-11-18
GB0407828D0 (en) 2004-05-12
MXPA05010790A (es) 2006-07-10
EP1610814B8 (de) 2010-06-02
EP1610814A1 (de) 2006-01-04
GB0307989D0 (en) 2003-05-14
HK1087328A1 (en) 2006-10-13

Similar Documents

Publication Publication Date Title
DE60115842D1 (de) Ventilanordnung
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
MX2010004074A (es) Combinacion 059.
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EP2298862A3 (de) Mesenchymale Stammzellen und deren Verwendungen
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
WO2005049000A3 (en) Treatment of phenylketonurias with bh4
EA200601107A1 (ru) Композиции, получаемые из морских растений, для обеспечения питания для старческой и поврежденной окружающей средой кожи
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
SI1968573T1 (sl) Uporaba benzo-kondenziranih heterocikliäśnih sulfamidnih derivatov za zdravljenje manije in bipolarne motnje
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
HK1075403A1 (en) Treatment of mastalgia with 4-hydroxy tamoxifen
HK1087328A1 (en) Therapeutic composition for autoimmune conditions
TR201901268T4 (tr) Mezenkimal kök hücreleri ve bunların kullanımları.
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
SE0004101D0 (sv) New use
WO2004043373A3 (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
HUP0302748A2 (hu) Nagy szárítóképességgel rendelkező növényi olajat tartalmazó gombaölő készítmény
MXPA04007491A (es) Tratamiento profilactico y terapeutico de infecciones y otras enfermedades con compuestos inmunoefectores.
PL1599211T3 (pl) Zastosowanie izorhamnetyny do leczenia nastrojów i chorób depresyjnych
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
IL175019A0 (en) Cxcl8 antagonists, their preparation and use
IL154775A (en) 21-hydroxy- 6,19-oxidoprogesterone (21oh-6, 19op) analogues, their preparation and use
NO20062138L (no) Anvendelse av ifenprodil i behandling av smerte

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties